{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:41:13Z","timestamp":1793648473783,"version":"4.5.1"},"reference-count":61,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,8]]},"DOI":"10.1093\/ije\/29.4.637","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T22:23:22Z","timestamp":1027722202000},"page":"637-644","source":"Crossref","is-referenced-by-count":58,"title":["Risk factors for benign proliferative breast disease"],"prefix":"10.1093","volume":"29","author":[{"given":"CM","family":"Friedenreich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HE","family":"Bryant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Hugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Danyluk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DL","family":"Page","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2000,8]]},"reference":[{"key":"key\n\t\t\t\t20170712061332_R1","doi-asserted-by":"crossref","unstructured":"Goehring C, Morabia A. Epidemiology of benign breast disease, with special attention to histologic types. Epidemiol Rev1997;19:310\u201327.","DOI":"10.1093\/oxfordjournals.epirev.a017960"},{"key":"key\n\t\t\t\t20170712061332_R2","doi-asserted-by":"crossref","unstructured":"Ernster VL. The epidemiology of benign breast disease. Epidemiol Rev1981;3:184\u2013202.","DOI":"10.1093\/oxfordjournals.epirev.a036233"},{"key":"key\n\t\t\t\t20170712061332_R3","doi-asserted-by":"crossref","unstructured":"Bodian CA. Benign breast diseases, carcinoma in situ, and breast cancer risk. Epidemiol Rev1993;15:177\u201387.","DOI":"10.1093\/oxfordjournals.epirev.a036103"},{"key":"key\n\t\t\t\t20170712061332_R4","unstructured":"Page DL, Vander Zwaag R, Rogers LW, Williams LT, Walker WE, Hartman WH. Relation between component parts of fibrocystic disease complex and breast cancer. J Natl Cancer Inst1978;61: 1055\u201363."},{"key":"key\n\t\t\t\t20170712061332_R5","doi-asserted-by":"crossref","unstructured":"Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med1985;312:146\u201351.","DOI":"10.1056\/NEJM198501173120303"},{"key":"key\n\t\t\t\t20170712061332_R6","doi-asserted-by":"crossref","unstructured":"Page DL, Dupont WD, Rogers LW, Rados MS. Atypical hyperplastic lesions of the female breast: a long-term follow-up study. Cancer1985;55:2698\u2013708.","DOI":"10.1002\/1097-0142(19850601)55:11<2698::AID-CNCR2820551127>3.0.CO;2-A"},{"key":"key\n\t\t\t\t20170712061332_R7","unstructured":"Fitzgibbons PL, Henson DE, Hutter RVP. Benign breast changes and the risk for subsequent breast cancer. An update of the 1985 consensus statement. Arch Pathol Med1998;122:1053\u201355."},{"key":"key\n\t\t\t\t20170712061332_R8","doi-asserted-by":"crossref","unstructured":"Bartow SA, Pathak DR, Black WC, Key CR, Teaf SR. Prevalence of benign, atypical, and malignant breast lesions in populations at different risk for breast cancer: a forensic autopsy study. Cancer1987;60: 2751\u201360.","DOI":"10.1002\/1097-0142(19871201)60:11<2751::AID-CNCR2820601127>3.0.CO;2-M"},{"key":"key\n\t\t\t\t20170712061332_R9","doi-asserted-by":"crossref","unstructured":"Ory H, Cole P, MacMahon B, Hoover R. Oral contraceptives and reduced risk of benign breast diseases. N Engl J Med1976;294: 419\u201322.","DOI":"10.1056\/NEJM197602192940804"},{"key":"key\n\t\t\t\t20170712061332_R10","doi-asserted-by":"crossref","unstructured":"Cole P, Elwood JM, Kaplan SD. Incidence rates and risk factors of benign breast neoplasms. Am J Epidemiol1978;108:112\u201320.","DOI":"10.1093\/oxfordjournals.aje.a112594"},{"key":"key\n\t\t\t\t20170712061332_R11","doi-asserted-by":"crossref","unstructured":"Fleming NT, Armstrong BK, Sheiner HJ. The comparative epidemiology of benign breast lumps and breast cancer in Western Australia. Int J Cancer1982;30:147\u201352.","DOI":"10.1002\/ijc.2910300204"},{"key":"key\n\t\t\t\t20170712061332_R12","doi-asserted-by":"crossref","unstructured":"Jick SS, Walker AM, Jick H. Conjugated estrogens and fibrocystic breast disease. Am J Epidemiol1986;124:746\u201351.","DOI":"10.1093\/oxfordjournals.aje.a114450"},{"key":"key\n\t\t\t\t20170712061332_R13","doi-asserted-by":"crossref","unstructured":"Wolf AM, Hunter DJ, Colditz GA et al. Reproducibility and validity of a self-administered physical activity questionnaire. Int J Epidemiol1994;23:991\u201399.","DOI":"10.1093\/ije\/23.5.991"},{"key":"key\n\t\t\t\t20170712061332_R14","doi-asserted-by":"crossref","unstructured":"Ainsworth BE, Haskell WL, Leon AS et al. Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sports Exerc1993;25:71\u201380.","DOI":"10.1249\/00005768-199301000-00011"},{"key":"key\n\t\t\t\t20170712061332_R15","unstructured":"Pennington JAT. Supplementary Tables: Caffeine. In: Bowes and Church's Food Values of Portions Commonly Used. Philadelphia, PA: JB Lippincott Co., 1994, pp.381\u201383."},{"key":"key\n\t\t\t\t20170712061332_R16","unstructured":"Pennington JAT. Supplementary tables: alcohol (ethanol) content of alcoholic beverages. In: Bowes and Church's Food Values of Portions Commonly Used. Philadelphia, PA: JB Lippincott Co., 1994, p.378."},{"key":"key\n\t\t\t\t20170712061332_R17","doi-asserted-by":"crossref","unstructured":"Byng JW, Yaffe MJ, Jong RA et al. Analysis of mammographic density and breast cancer risk. Radiographics1998;18:1587\u201398.","DOI":"10.1148\/radiographics.18.6.9821201"},{"key":"key\n\t\t\t\t20170712061332_R18","doi-asserted-by":"crossref","unstructured":"Tabar L, Fagerberg G, Duffy SW, Day NE, Gad A, Grontoft O. Update of the Swedish Two-County program of mammographic screening for breast cancer. Radiol Clin N Am1992;30:187\u2013209.","DOI":"10.1016\/S0033-8389(22)02494-0"},{"key":"key\n\t\t\t\t20170712061332_R19","unstructured":"Europe Against Cancer. European Guidelines for Quality Assurance in Mammographic Screening. European Commission, June 1996."},{"key":"key\n\t\t\t\t20170712061332_R20","unstructured":"Standards for the NHS Breast Screening Programme. NHSBSP, 1993."},{"key":"key\n\t\t\t\t20170712061332_R21","doi-asserted-by":"crossref","unstructured":"Byng J, Boyd NF, Yaffe M. Quantitative assessment of mammographic densities. Phys Med Biol1994;39:1629\u201338.","DOI":"10.1088\/0031-9155\/39\/10\/008"},{"key":"key\n\t\t\t\t20170712061332_R22","doi-asserted-by":"crossref","unstructured":"Bianchi S, Palli D, Galli M, Zampi G. Benign breast disease and cancer risk. Crit Rev Oncol\/Hematol1993;15:221\u201342.","DOI":"10.1016\/1040-8428(93)90043-4"},{"key":"key\n\t\t\t\t20170712061332_R23","doi-asserted-by":"crossref","unstructured":"Yu H, Rohan TE, Cook MG, Howe GR, Miller AB. Risk factors for fibroadenoma: a case-control study in Australia. Am J Epidemiol1992; 135:247\u201358.","DOI":"10.1093\/oxfordjournals.aje.a116278"},{"key":"key\n\t\t\t\t20170712061332_R24","doi-asserted-by":"crossref","unstructured":"Parazzini F, Ferraroni M, La Vecchia C et al. Smoking habits and risk of benign breast disease. Int J Epidemiol1991;20:430\u201334.","DOI":"10.1093\/ije\/20.2.430"},{"key":"key\n\t\t\t\t20170712061332_R25","doi-asserted-by":"crossref","unstructured":"Rohan TE, Cook MG, Baron JA. Cigarette smoking and benign proliferative epithelial disorders of the breast in women: a case-control study. J Epidemiol Community Health1989;43:362\u201368.","DOI":"10.1136\/jech.43.4.362"},{"key":"key\n\t\t\t\t20170712061332_R26","unstructured":"Rohan TE, Baron JA. Cigarette smoking and benign breast disease. In: Wald N, Baron JA, (eds). Smoking and Hormone-related Disorders. New York, NY: Oxford University Press, 1990, pp.72\u201380."},{"key":"key\n\t\t\t\t20170712061332_R27","doi-asserted-by":"crossref","unstructured":"Mant D, Vessey MP, Smith MA, Yeates D. Cigarette smoking and benign breast disease (Letter). J Epidemiol Community Health1986;40: 277\u201378.","DOI":"10.1136\/jech.40.3.277"},{"key":"key\n\t\t\t\t20170712061332_R28","doi-asserted-by":"crossref","unstructured":"Berkowitz GS, Canny PF, Livolsi VA, Merino MJ, O'Connor TZ, Kelsey JL. Cigarette smoking and benign breast disease. J Epidemiol Community Health1985;39:308\u201313.","DOI":"10.1136\/jech.39.4.308"},{"key":"key\n\t\t\t\t20170712061332_R29","doi-asserted-by":"crossref","unstructured":"Pastides H, Najjar MA, Kelsey JL. Estrogen replacement therapy and fibrocystic breast disease. Am J Prev Med1987;3:282\u201386.","DOI":"10.1016\/S0749-3797(18)31247-9"},{"key":"key\n\t\t\t\t20170712061332_R30","doi-asserted-by":"crossref","unstructured":"Nomura A, Comstock GW, Tonascia JA. Epidemiologic characteristics of benign breast disease. Am J Epidemiol1977;105:505\u201312.","DOI":"10.1093\/oxfordjournals.aje.a112413"},{"key":"key\n\t\t\t\t20170712061332_R31","unstructured":"Boyle CA, Berkowitz GS, LiVolsi VA et al. Caffeine consumption and fibrocystic breast disease: a case-control epidemiologic study. J Natl Cancer Inst1984;72:1015\u201319."},{"key":"key\n\t\t\t\t20170712061332_R32","unstructured":"La Vecchia C, Franceschi S, Parazzini F et al. Benign breast disease and consumption of beverages containing methylxanthines. J Natl Cancer Inst1985;74:995\u20131000."},{"key":"key\n\t\t\t\t20170712061332_R33","doi-asserted-by":"crossref","unstructured":"Schairer C, Brinton LA, Hoover RN. Methylxanthines and benign breast disease. Am J Epidemiol1986;124:603\u201311.","DOI":"10.1093\/oxfordjournals.aje.a114433"},{"key":"key\n\t\t\t\t20170712061332_R34","doi-asserted-by":"crossref","unstructured":"Lubin F, Ron E, Wax Y, Black M, Funaro M, Shitrit A. A case-control study of caffeine and methylxanthines in benign breast disease. JAMA1985;253:2388\u201392.","DOI":"10.1001\/jama.253.16.2388"},{"key":"key\n\t\t\t\t20170712061332_R35","doi-asserted-by":"crossref","unstructured":"Rohan TE, Cook MG, McMichael AJ. Methylxanthines and proliferative epithelial disorders of the breast in women. Int J Epidemiol1989; 18:626\u201333.","DOI":"10.1093\/ije\/18.3.626"},{"key":"key\n\t\t\t\t20170712061332_R36","doi-asserted-by":"crossref","unstructured":"Rohan TE, Cook MG. Alcohol consumption and risk of benign proliferative epithelial disorders of the breast in women. Int J Cancer1989;43:631\u201336.","DOI":"10.1002\/ijc.2910430416"},{"key":"key\n\t\t\t\t20170712061332_R37","unstructured":"Trapido EJ, Brinton LA, Schairer C, Hoover R. Estrogen replacement therapy and benign breast disease. J Natl Cancer Inst1984;73:1101\u201305."},{"key":"key\n\t\t\t\t20170712061332_R38","doi-asserted-by":"crossref","unstructured":"Berkowitz GS, Kelsey JL, LiVolsi VA et al. Exogenous hormone use and fibrocystic breast disease by histopathologic component. Int J Cancer1984;34:443\u201349.","DOI":"10.1002\/ijc.2910340403"},{"key":"key\n\t\t\t\t20170712061332_R39","doi-asserted-by":"crossref","unstructured":"Berkowitz GS, Kelsey JL, Holford TR et al. Estrogen replacement therapy and fibrocystic breast disease in postmenopausal women. Am J Epidemiol1985;121:238\u201345.","DOI":"10.1093\/oxfordjournals.aje.a113994"},{"key":"key\n\t\t\t\t20170712061332_R40","doi-asserted-by":"crossref","unstructured":"Sartwell PE, Arthes FG, Tonascia JA. Epidemiology of benign breast lesions: lack of association with oral contraceptive use. N Engl J Med1973;288:551\u201354.","DOI":"10.1056\/NEJM197303152881104"},{"key":"key\n\t\t\t\t20170712061332_R41","doi-asserted-by":"crossref","unstructured":"Parazzini F, La Vecchia C, Franceschi S et al. Risk factors for pathologically confirmed benign breast disease. Am J Epidemiol1984;120: 115\u201322.","DOI":"10.1093\/oxfordjournals.aje.a113860"},{"key":"key\n\t\t\t\t20170712061332_R42","doi-asserted-by":"crossref","unstructured":"Ravnihar B, Seigel DG, Lindtner J. An epidemiologic study of breast cancer and benign breast neoplasias in relation to oral contraceptive and estrogen use. Eur J Cancer1979;15:395\u2013405.","DOI":"10.1016\/0014-2964(79)90074-4"},{"key":"key\n\t\t\t\t20170712061332_R43","doi-asserted-by":"crossref","unstructured":"Bright RA, Morrison AS, Brisson J et al. Histologic and mammographic specificity of risk factors for benign breast disease. Cancer1989; 64:653\u201357.","DOI":"10.1002\/1097-0142(19890801)64:3<653::AID-CNCR2820640315>3.0.CO;2-O"},{"key":"key\n\t\t\t\t20170712061332_R44","doi-asserted-by":"crossref","unstructured":"Brinton LA, Vessey MP, Flavel R, Yeates D. Risk factors for benign breast disease. Am J Epidemiol1981;113:203\u201314.","DOI":"10.1093\/oxfordjournals.aje.a113089"},{"key":"key\n\t\t\t\t20170712061332_R45","doi-asserted-by":"crossref","unstructured":"Canny PF, Berkowitz GS, Kelsey JL, LiVolsi VA. Fibroadenoma and the use of exogenous hormones: a case-control study. Am J Epidemiol1988;127:454\u201361.","DOI":"10.1093\/oxfordjournals.aje.a114822"},{"key":"key\n\t\t\t\t20170712061332_R46","doi-asserted-by":"crossref","unstructured":"Kelsey JL, Lindfors KK, White C. A case-control study of the epidemiology of benign breast diseases with reference to oral contraceptive use. Int J Epidemiol1974;3:333\u201340.","DOI":"10.1093\/ije\/3.4.333"},{"key":"key\n\t\t\t\t20170712061332_R47","doi-asserted-by":"crossref","unstructured":"Kelsey JL, Holford TR, White C, Mayer ES, Kilty SE, Acheson RM. Oral contraceptives and breast disease: an epidemiological study. Am J Epidemiol1978;107:236\u201344.","DOI":"10.1093\/oxfordjournals.aje.a112530"},{"key":"key\n\t\t\t\t20170712061332_R48","doi-asserted-by":"crossref","unstructured":"Franceschi S, La Vecchia C, Parazzini F et al. Oral contraceptives and benign breast disease: a case-control study. Am J Obstet Gynecol1984;149:602\u201306.","DOI":"10.1016\/0002-9378(84)90242-4"},{"key":"key\n\t\t\t\t20170712061332_R49","doi-asserted-by":"crossref","unstructured":"Vessey MP, Doll R, Sutton PM. Investigation of the possible relationship between oral contraceptives and benign and malignant breast disease. Cancer1971;28:1395\u201399.","DOI":"10.1002\/1097-0142(197112)28:6<1395::AID-CNCR2820280610>3.0.CO;2-5"},{"key":"key\n\t\t\t\t20170712061332_R50","unstructured":"Pastides H, Kelsey JL, LiVolsi VA, Holford TR, Fischer DB, Goldenberg IS. Oral contraceptive use and fibrocystic breast disease with special reference to its histopathology. J Natl Cancer Inst1983;71:5\u20139."},{"key":"key\n\t\t\t\t20170712061332_R51","doi-asserted-by":"crossref","unstructured":"Lees AW, Burns PE, Grace M. Oral contraceptives and breast disease in premenopausal northern Alberta women. Int J Cancer1978;22: 700\u201307.","DOI":"10.1002\/ijc.2910220611"},{"key":"key\n\t\t\t\t20170712061332_R52","unstructured":"Hsieh CC, Crosson AW, Walker AM, Trapido EJ, MacMahon B. Oral contraceptive use and fibrocystic breast disease of different histologic classifications. J Natl Cancer Inst1984;72:285\u201390."},{"key":"key\n\t\t\t\t20170712061332_R53","doi-asserted-by":"crossref","unstructured":"LiVolsi VA, Stadel BV, Kelsey JL, Holford TR, White C. Fibrocystic breast disease in oral-contraceptive users: a histopathological evaluation of epithelial atypia. N Engl J Med1978;299:381\u201385.","DOI":"10.1056\/NEJM197808242990803"},{"key":"key\n\t\t\t\t20170712061332_R54","doi-asserted-by":"crossref","unstructured":"Berkowitz GS, Kelsey JL, LiVolsi VA et al. Oral contraceptive use and fibrocystic breast disease among pre- and postmenopausal women. Am J Epidemiol1984;120:87\u201396.","DOI":"10.1093\/oxfordjournals.aje.a113878"},{"key":"key\n\t\t\t\t20170712061332_R55","doi-asserted-by":"crossref","unstructured":"Soini I, Aine R, Lauslahti K, Hakama M. Independent risk factors of benign and malignant breast lesions. Am J Epidemiol1981;114: 507\u201314.","DOI":"10.1093\/oxfordjournals.aje.a113216"},{"key":"key\n\t\t\t\t20170712061332_R56","unstructured":"Hislop TG, Elwood JM. Risk factors for benign breast disease: a 30-year cohort study. Can Med Assoc J1981;124:283\u201391."},{"key":"key\n\t\t\t\t20170712061332_R57","doi-asserted-by":"crossref","unstructured":"Pastides H, Kelsey JL, Holford TR, LiVolsi VA. An epidemiologic study of fibrocystic breast disease with reference to ductal epithelial atypia. Am J Epidemiol1985;121:440\u201347.","DOI":"10.1093\/oxfordjournals.aje.a114016"},{"key":"key\n\t\t\t\t20170712061332_R58","doi-asserted-by":"crossref","unstructured":"London SJ, Stein EA, Henderson IC et al. Carotenoids, retinol, and vitamin E and risk of proliferative benign breast disease and breast cancer. Cancer Causes Control1992;3:503\u201312.","DOI":"10.1007\/BF00052746"},{"key":"key\n\t\t\t\t20170712061332_R59","unstructured":"Simard A, Vobecky J, Vobecky JS. Nutrition and lifestyle factors in fibrocystic disease and cancer of the breast. Cancer Detect Prev1990;14:567\u201372."},{"key":"key\n\t\t\t\t20170712061332_R60","doi-asserted-by":"crossref","unstructured":"Ingram D, Nottage E, Ng S, Sparrow L, Roberts A, Willcox D. Obesity and breast disease: the role of female sex hormones. Cancer1989;64:1049\u201353.","DOI":"10.1002\/1097-0142(19890901)64:5<1049::AID-CNCR2820640515>3.0.CO;2-M"},{"key":"key\n\t\t\t\t20170712061332_R61","doi-asserted-by":"crossref","unstructured":"Hislop TG, Band PR, Deschamps M et al. Diet and histologic types of benign breast disease defined by subsequent risk of breast cancer. Am J Epidemiol1990;131:263\u201370.","DOI":"10.1093\/oxfordjournals.aje.a115496"}],"container-title":["International Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ije\/article-pdf\/29\/4\/637\/18477831\/290637.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T03:39:49Z","timestamp":1682221189000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ije\/article-lookup\/doi\/10.1093\/ije\/29.4.637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,8]]},"references-count":61,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2000,8]]},"published-print":{"date-parts":[[2000,8]]}},"URL":"https:\/\/doi.org\/10.1093\/ije\/29.4.637","relation":{},"ISSN":["1464-3685","0300-5771"],"issn-type":[{"value":"1464-3685","type":"electronic"},{"value":"0300-5771","type":"print"}],"subject":[],"published":{"date-parts":[[2000,8]]}}}